WHO ICTRP trial
Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial…
ISRCTN87711003 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN87711003 |
|---|---|
| Public title | Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy |
| Scientific title | Anticoagulation using the direct factor Xa inhibitor apixaban during atrial fibrillation catheter ablation and comparison to vitamin K antagonist therapy: A investigator-initiated, prospective, parallel-group, randomised, open, blinded outcome assessment (PROBE) interventional multi-centre trial. |
| Primary sponsor | Kompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork] |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | Austria;Belgium;Denmark;Germany;Italy;Netherlands;Spain;United Kingdom;United States of America |
| Conditions | Non-valvular atrial fibrillation with a clinical indication for catheter ablation/bleeding + stroke risk/cardiology Circulatory System Atrial fibrillation |
| Interventions | Anticoagulation therapy with new oral anticoagulants and vitamin-k-antagonists during atrial fibrillation ablation |
| Registration date | Jun 20, 2014 |
| Target size | 630 |
| Secondary IDs | 2014-002442-45;NCT02227550;N/A |
| Registry page | isrctn.com |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: